FMF is widely distributed in populations inhabiting the Mediterranean basin
. It is mainly attributed to five founder mutations (M680I, M694V, M694I, V
726A, E148Q) in the MEFV gene. The frequencies and distribution of these mu
tations in 146 FMF patients, of Arab and Jewish descent, were compared to t
hat observed in 1173 healthy individuals of pertinent ethnic groups. Five m
utations accounted for 91% of FMF chromosomes in our patients. Mutation M69
4V, predominant in North African Jews, was observed in all patients other t
han Ashkenazi Jews; mutation V726A was prevalent among all patients other t
han North African Jews; mutations M6941 and M6801 were mainly confined to A
rab patients. Overall carrier rates, for four mutations (M6801, M694V, V726
A, E148Q), were extremely high in our healthy cohort composed of Ashkenazi
(n=407); Moroccan (n=243); Iraqi Jews (n=205); and Muslim Arabs (n=318); ca
lculated at 1:4.5; 1:4.7; 1:3.5 and 1:4.3 respectively. The V726A allele pr
evalent among Ashkenazi and Iraq! Jews and Muslim Arabs (carrier rates: 7.4
, 12.8 and 7.3%, respectively) was not found among Moroccan Jews. The M694V
allele detected among Moroccan and Iraqi Jews and Muslim Arabs (carrier ra
tes 11.1, 2.9 and 0.6%, respectively) was not observed among Ashkenazim. Th
e overall frequency of mutations V726A and E148Q in Ashkenazim, Iraqi Jews
and Arabs indicates that the bulk of individuals that comply with the genet
ic definition of FMF remain asymptomatic.